Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotfrit, Joanna, Goodwin, Rachel, Asmis, Timothy, Hyde, Angela J., Alcindor, Thierry, Aubin, Francine, Berry, Scott, Bossé, Dominick, Brown, Colin, Burkes, Ronald, Burnell, Margot, Colwell, Bruce, Corbett, Jessica, Craswell, Jeff, Daaboul, Nathalie, Doherty, Mark, Fleming, D. A. Barry, Galvis, Luisa, Goel, Rakesh, Harb, Mohammed, Jeyakumar, Alwin, Jonker, Derek, Kennedy, Erin, Lock, Michael, Mahmud, Aamer, McCrea, Patrick H., Nair, Vimoj, Nassabein, Rami, Nessim, Carolyn, Ramjeesingh, Ravi, Raza, Muhammad, Saliba, Wissam, Samimi, Satareh, Singh, Simron, Snow, Stephanie, Tehfé, Mustapha, Thirlwell, Michael, Valdes, Mario, Welch, Stephen, Vickers, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161825/
https://www.ncbi.nlm.nih.gov/pubmed/34073199
http://dx.doi.org/10.3390/curroncol28030185
Descripción
Sumario:The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized and advanced anal cancer; watch and wait strategy for the management of rectal cancer; role of testing for dihydropyrimidine dehydrogenase (DPD) deficiency prior to commencement of fluoropyrimidine therapy; radiotherapy and systemic therapy in the adjuvant and unresectable settings for biliary tract cancer; and radiotherapy and systemic therapy in the perioperative setting for early-stage gastric cancer.

Ejemplares similares